Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2023;34(4):414-17
Article Links
Is there a Role for Anti-IL-5 Therapies in Eosinophilic Fasciitis?
Andreas Angelopoulos1, Ioannis Kouverianos2, Dimitrios Daoussis3
Authors Information

1Internal Medicine Resident, General Hospital of East Achaia, Kalavryta, Greece

2Medical Graduate, University of Patras Medical School, Patras, Greece

3Department of Rheumatology, Patras University Hospital, University of Patras Medical School, Patras, Greece

A Angelopoulos, I Kouverianos, D Daoussis

Keywords: eosinophilic fasciitis, EF, groove sign, mepolizumab, benralizumab, reslizumab
References
  1. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians [Internet] 1975 [cited 2023 Mar 22];88:70–86. Available from: https://pubmed.ncbi.nlm.nih.gov/1224441/
  2. Lamback EB, Resende FSS, Lenzi TCR. Eosinophilic fasciitis. An Bras Dermatol [Internet] 2016 Sep 1 [cited 2023 Mar 22];91(5 suppl 1):57–9. Available from: https://pubmed.ncbi.nlm.nih.gov/28300895/
  3. Aun JA, Knox RS, Roberts JE. The enigmatic fascia: eosinophilic fasciitis. J Osteopath Med [Internet] 2021 Jun 1 [cited 2023 Mar 22];121(6):555–9. Available from: https://pubmed.ncbi.nlm.nih.gov/33783170/
  4. Ihn H. Eosinophilic fasciitis: From pathophysiology to treatment. Allergol Int [Internet] 2019 Oct 1 [cited 2022 Oct 6];68(4):437–9. Available from: https://pubmed.ncbi.nlm.nih.gov/30910631/
  5. Mortezavi M, Barrett M, Edrissian M. Successful treatment of refractory eosinophilic fasciitis with reslizumab. JAAD case reports [Internet] 2020 Sep 1 [cited 2022 Oct 17];6(9):951–3. Available from: https://pubmed.ncbi.nlm.nih.gov/32913886/
  6. Nagase H, Ueki S, Fujieda S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol Int [Internet] 2020 Apr 1 [cited 2023 Mar 22];69(2):178–86. Available from: https://pubmed.ncbi.nlm.nih.gov/32139163/
  7. Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA. Epidemiology and Treatment of Eosinophilic Fasciitis: An Analysis of 63 Patients From 3 Tertiary Care Centers. JAMA Dermatol [Internet] 2016 Jan 1 [cited 2023 Mar 22];152(1):97–9. Available from: https://pubmed.ncbi.nlm.nih.gov/26559760/
  8. Mertens JS, Seyger MMB, Thurlings RM, Radstake TRDJ, de Jong EMGJ. Morphea and Eosinophilic Fasciitis: An Update. Am J Clin Dermatol [Internet] 2017;18(4):491–512. Available from: https://pubmed.ncbi.nlm.nih.gov/28303481/
  9. Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum [Internet] 1988 [cited 2022 Oct 11];17(4):221–31. Available from: https://pubmed.ncbi.nlm.nih.gov/3232080/
  10. Granter SR, Barnhill RL, Duray PH. Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol [Internet] 1996 [cited 2023 Mar 22];18(5):465–73. Available from: https://pubmed.ncbi.nlm.nih.gov/8902092/
  11. Hashimoto Y, Takahashi H, Matsuo S, Hirai K, Takemori N, Nakao M, et al. Polymerase chain reaction of Borrelia burgdorferi flagellin gene in Shulman syndrome. Dermatology [Internet] 1996 [cited 2023 Mar 22];192(2):136–9. Available from: https://pubmed.ncbi.nlm.nih.gov/8829496/
  12. Ollier N, Tournier E, Meyer N, Sibaud V, Pages-Laurent C, Cougoul P, et al. Nivolumab-induced eosinophilic fasciitis: a case report. Rheumatol Adv Pract [Internet] 2020;4(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32064454/
  13. Chan KK, Magro C, Shoushtari A, Rudin C, Rotemberg V, Rossi A, et al. Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature. Oncologist [Internet] 2020 Feb 1 [cited 2023 Mar 22];25(2):140–9. Available from: https://pubmed.ncbi.nlm.nih.gov/32043775/
  14. De Masson A, Bouaziz JD, De Latour RP, Benhamou Y, Moluçon-Chabrot C, Bay JO, et al. Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature. Medicine (Baltimore) [Internet] 2013 Mar [cited 2023 Mar 22];92(2):69–81. Available from: https://pubmed.ncbi.nlm.nih.gov/23429351/
  15. Ansari S, Iftikhar U, Jamil A, Ansari A, Iftikhar S. Eosinophilic Fasciitis With a Malignant Outcome. J Med Cases [Internet] 2021;12(6):220–2. Available from: https://pubmed.ncbi.nlm.nih.gov/34434461/
  16. Blackmond N, Kanke J, Brown K, Weitzman R. Eosinophilic Fasciitis: A Rare and Challenging Diagnosis in a Free Clinic Setting. Cureus [Internet] 2022 Jun 5 [cited 2022 Oct 17];14(6). Available from: https://pubmed.ncbi.nlm.nih.gov/35812539/
  17. Camard M, Maisonobe T, Flamarion E. The groove sign in eosinophilic fasciitis. Clin Rheumatol [Internet] 2022 Dec 1 [cited 2023 Mar 22];41(12):3919–20. Available from: https://pubmed.ncbi.nlm.nih.gov/35907103/
  18. Korsten P. A “groovy” diagnosis: Eosinophilic fasciitis. Clin case reports [Internet] 2020 Dec 1 [cited 2022 Oct 6];8(12):3545–6. Available from: https://pubmed.ncbi.nlm.nih.gov/33363970/
  19. Jones HR, Beetham WP, Silverman ML, Margles SW. Eosinophilic fasciitis and the carpal tunnel syndrome. J Neurol Neurosurg Psychiatry [Internet] 1986 [cited 2023 Mar 22];49(3):324–7. Available from: https://pubmed.ncbi.nlm.nih.gov/3958745/
  20. Mazori DR, Kassamali B, Min MS, Schaefer M, Lachance AH, Sperling AS, et al. Characteristics and Outcomes of Eosinophilic Fasciitis-Associated Monoclonal Gammopathy. JAMA Dermatol [Internet] 2021 Dec 1 [cited 2023 Mar 22];157(12):1508–9. Available from: https://pubmed.ncbi.nlm.nih.gov/34705045/
  21. Nashel J, Steen V. The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis. Clin Rheumatol [Internet] 2015 Aug 7 [cited 2023 Mar 22];34(8):1481–4. Available from: https://pubmed.ncbi.nlm.nih.gov/25245261/
  22. Nakajima H, Fujiwara S, Shinoda K, Ohsawa N. Magnetic resonance imaging and serum aldolase concentration in eosinophilic fasciitis. Intern Med [Internet] 1997 [cited 2023 Mar 27];36(9):654–6. Available from: https://pubmed.ncbi.nlm.nih.gov/9313113/
  23. Rea A, Anderson A, Moshiri A, Paulson K, Thompson JA, Kalus A. Eosinophilic fasciitis as a paraneoplastic syndrome in melanoma. JAAD Case Rep [Internet] 2021 Nov 1 [cited 2022 Oct 6];17:49–51. Available from: https://pubmed.ncbi.nlm.nih.gov/34703864/
  24. Fleming CJ, Clarke P, Kemmett D. Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin. Br J Dermatol [Internet] 1997 [cited 2023 Mar 22];136(2):297–8. Available from: https://pubmed.ncbi.nlm.nih.gov/9068764/
  25. Antic M, Lautenschlager S, Itin PH. Eosinophilic fasciitis 30 years after - what do we really know? Report of 11 patients and review of the literature. Dermatology [Internet] 2006 Aug [cited 2023 Mar 22];213(2):93–101. Available from: https://pubmed.ncbi.nlm.nih.gov/16902285/
  26. Response to methotrexate in a patient with idiopathic eosinophilic fasciitis, morphea, IgM hypergammaglobulinemia, and renal involvement - PubMed [Internet] [cited 2023 Mar 22]. Available from: https://pubmed.ncbi.nlm.nih.gov/8992001/
  27. Kougkas N, Bertsias G, Papalopoulos I, Repa A, Sidiropoulos P, Avgoustidis N. Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review. Rheumatol Int [Internet] 2021 Oct 1 [cited 2023 Mar 22];41(10):1833–7. Available from: https://pubmed.ncbi.nlm.nih.gov/34009397/
  28. Schiener R, Behrens-Williams SC, Gottlöber P, Pillekamp H, Peter RU, Kerscher M. Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy. Br J Dermatol [Internet] 2000 [cited 2023 Mar 22];142(4):804–7. Available from: https://pubmed.ncbi.nlm.nih.gov/10792237/